Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year follow-up from two phase III studies - Martorell C; Ramgopal M; Hagins D; Osiyemi O; Arribas JR; Berhe M; Yazdanpanah Y; Orkin C; Santiago L; Rosero C; Unger N; Liu H; et al. (Hiv Medicine, 2025)